Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-014310-94Phase 4Active
Phase 4, randomised, open-label trial of capecitabine in rectal adenocarcinoma (2 arms), sponsored by Hospital Universitari Parc Taulí. Primary endpoint: Local recurrence. Started Oct 2009; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-014310-94.